发明名称 |
Sustained-release once-a-day oral dosage oxycodone formulations |
摘要 |
The disclosure relates to a sustained-release oral dosage form for once-a-day administration comprising: a pharmaceutically acceptable sustained-release matrix comprising, as part of the sustained-release matrix, (a) an analgesially effective amount of oxycodone in the range from 1 mg to 640 mg of oxycodone or a pharmaceutically acceptable salt thereof, and (b) a sustained release material in an effective amount to render the dosage form suitable for once-a-day oral administration, the sustained-release matrix coated with a coating, wherein the dosage form provides a sustained release effect for at least about 24 hours and a mean C24/Cmax oxycodone ratio of 0.7 to 0.99 after once-a-day steady state oral administration to human patients. |
申请公布号 |
NZ587010(A) |
申请公布日期 |
2012.03.30 |
申请号 |
NZ20020587010 |
申请日期 |
2002.05.02 |
申请人 |
EURO-CELTIQUE S.A. |
发明人 |
OSHLACK, BENJAMIN;PRATER, DEREK ALLAN;WRIGHT, CURTIS |
分类号 |
A61K9/26;A61K9/00;A61K9/16;A61K9/20;A61K9/22;A61K9/24;A61K9/30;A61K9/32;A61K9/36;A61K9/44;A61K9/48;A61K9/50;A61K9/52;A61K9/56;A61K31/485;A61P25/04 |
主分类号 |
A61K9/26 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|